Antiviral Treatments Eliminate the Adverse Impacts of High Baseline HBV Loads on the Survival of HBV-Related HCC Patients

BACKGROUND: In consideration of no standard exclusion criteria for hepatitis B virus (HBV) loads in hepatocellular carcinoma (HCC)-related clinical trials, this study aimed to investigate the prevalence of HBV-related exclusion criteria among current clinical trials and evaluate whether antiviral tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Zili, Sun, Xuqi, Mei, Jie, Hu, Zhiwen, Yang, Ziliang, Hou, Jingyu, Fu, Yizhen, Wang, Xiaohui, Chen, Minshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9034869/
https://www.ncbi.nlm.nih.gov/pubmed/35469289
http://dx.doi.org/10.2147/JHC.S363123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9034869/
https://www.ncbi.nlm.nih.gov/pubmed/35469289
http://dx.doi.org/10.2147/JHC.S363123

Ejemplares similares